Clinicodemographic Aspect of Resectable Pancreatic Cancer and Prognostic Factors for Resectable Cancer

World Journal of Surgical Oncology - United Kingdom
doi 10.1186/1477-7819-10-77
Full Text
Abstract

Available in full text

Categories
SurgeryOncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Pancreatic Cancer Is ‘Always Non-Resectable’

Digestive Diseases
MedicineGastroenterology
2007English

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2017English

Cutting‐edge Strategies for Borderline Resectable Pancreatic Cancer

Annals of Gastroenterological Surgery
2019English

Resectable Pancreatic Cancer Needs Surgery, Then Chemotherapy

BMJ
2004English

Preoperative Predictors for Early Recurrence of Resectable Pancreatic Cancer

World Journal of Surgical Oncology
SurgeryOncology
2017English

Improving Outcomes in Patients With Resectable Pancreatic Cancer

British Journal of Surgery
Surgery
2017English

A Decision Model of Therapy for Potentially Resectable Pancreatic Cancer

Journal of Surgical Research
Surgery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy